EP4084778
Ókristallaðar kínasa-hindra samsetningar og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.12.2020EP published:
1.11.2023EP application number:
20845854.7
EP translation filed:
27.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
29.12.2040Expiry date:
29.12.2026Next due date:
31.12.2026
Title in English:
AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
30.12.2020EP application
1.11.2023EP Publication
27.11.2023Translation submitted
15.12.2023Registration published
29.12.2026Expires
Owner
Name:
Deciphera Pharmaceuticals, LLCAddress:
200 Smith Street, Waltham, MA 02451, US
Inventor
Name:
KAUFMAN, Michael, D.Address:
Waltham, MA 02451, US
Name:
BONE, ScottAddress:
Bend, OR 97703, US
Name:
BLOOM, CoreyAddress:
Bend, OR 97703, US
Name:
JORDAN, FredAddress:
Bend, OR 97703, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962955062 PDate:
30.12.2019Country:
US
Number:
201962955073 PDate:
30.12.2019Country:
US
Number:
202062968695 PDate:
31.1.2020Country:
US
Number:
202062968724 PDate:
31.1.2020Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 31/4375, C07D 471/04, A61K 31/00, A61P 35/00, C07C 15/00, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 15.12.2023
Expires: 29.12.2024
Payer: Árnason Faktor ehf.
Number: 4
Paid: 15.12.2023
Expires: 29.12.2024
Payer: Árnason Faktor ehf.
Number: 5
Paid: 10.12.2024
Expires: 29.12.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 19.12.2025
Expires: 29.12.2026
Payer: Árnason Faktor ehf.